Fingerprint
Dive into the research topics of 'Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma
Arielle G. Bensimon, Yichen Zhong, Umang Swami, Allison Briggs, Joshua Young, Yuan Feng, Yan Song, James Signorovitch, Oluwakayode Adejoro, Abhiroop Chakravarty, Mei Chen, Rodolfo F. Perini, Daniel M. Geynisman
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations